Compare New York Times Co (NYT) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
New York Times Co vs Teladoc Health Inc — how do they compare? New York Times Co trades at $66.6 (market cap $10.96B), while Teladoc Health Inc trades at $6.09 (market cap $1.14B). The key difference: New York Times Co is far larger — about 9.6× Teladoc Health Inc's market cap, and New York Times Co pays a 1.35% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| NYT | TDOC | |
|---|---|---|
Market Cap | $10.96B | $1.14B |
Sector | Media | Health |
52-Week High | $85.86 | $9.72 |
52-Week Low | $54.66 | $4.47 |
Enterprise Value | $10.36B | $1.40B |
Dividend Yield | 1.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The New York Times Company (NYT) trades at $67.96, up 1.01% today, with a neutral technical signal. Recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 highlight strong operational performance, supported by rising revenue and net income margins. The stock's valuation metrics include a P/E of 28.32 and P/S of 3.75, while positive cash flow trends and a dividend payment reflect financial stability.
Outlook remains cautiously optimistic with a consensus price target of $76.00, offering potential upside. Key risks include ongoing legal challenges with OpenAI over copyright issues and competitive pressures in digital media. Institutional interest is evident, but regulatory and market sentiment uncertainties warrant monitoring for sustained growth.
TDOC trades at $6.26, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $200.32 million in 2025, though revenue remains stable at $2.53 billion. Analyst consensus is a hold with a $8.88 price target, while recent news highlights leadership changes and ongoing legal investigations.
The outlook is cautious; while valuation ratios like P/S of 0.45 and EV/EBITDA of 6.5 appear attractive, persistent losses and negative ROE of -12.99% pose risks. Upside depends on profitability improvements under new CFO Michael Grasher, but investor sentiment is tempered by weak earnings and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About New York Times Co
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
